Related Experiment Video
Updated: Jul 7, 2025

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Off-Label Prescribing in Pediatric Population-Literature Review for 2012-2022
Valentina Petkova1, Dilyana Georgieva2, Milen Dimitrov2
1Department of Social Pharmacy, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
Insights
Off-label prescribing in pediatrics is a significant global issue. This study reviewed literature from 2012-2022 to understand the prevalence of using medications outside their approved indications for children.
Area of Science:
- Pediatric Pharmacology
- Drug Utilization Research
- Clinical Pharmacy
Background:
- Off-label prescribing is common in pediatrics, posing global health concerns.
- The practice is influenced by patient condition, physician expertise, regulations, and the pharmaceutical industry.
- Ensuring patient safety, especially for critically ill children, is paramount.
Purpose of the Study:
- To investigate the prevalence of off-label drug use in pediatric populations.
- To synthesize current data on pediatric off-label prescribing trends.
Main Methods:
- Conducted a literature review.
- Included studies published between 2012 and 2022.
- Focused on research evaluating off-label drug prevalence in diverse pediatric groups.
Main Results:
- Off-label medication use is widespread among pediatricians.
- Significant global concern exists regarding the use of unapproved medicines in children.
- Data from 2012-2022 indicates ongoing prevalence across various pediatric patient groups.
Conclusions:
- Off-label prescribing in children remains a complex and prevalent issue.
- A unified legal framework is unlikely in the near future.
- Prioritizing patient well-being, particularly for those in neonatal and pediatric intensive care units, is essential.
Abstract:
Off-label prescribing is widespread among pediatricians, and it is unlikely that this trend will soon be bound by a uniform legal framework. This is necessitated by the fact that there are four variables: the patient's health condition, the physician's experience and knowledge, the legislative measures (laws, directives, guidelines, and recommendations), and finally, the pharmaceutical industry. There is considerable concern worldwide about the use of off-label medicines in children. We may call it an enormous global problem that is much talked about and written about; however, we should not forget that the goal around which everyone should unite is the patient's life. For healthcare providers, the most important thing will always be the health and preservation of the patient's life, particularly when it comes to children with life-threatening conditions in neonatal and pediatric intensive care units (NICU and PICU). The study aimed to examine the prevalence of off-label drug use in pediatrics. Literature research was conducted, and we included studies from 2012 to 2022 that evaluated off-label drug prevalence in various pediatric patient populations.
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Factors Affecting Drug Response: Overview
Drug Regulation
Drug Classes and Categories
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...

